CJC 1295: Popular Claims vs What Evidence Requires, CJC 1295 (often paired with ipamorelin) is marketed for fat loss, lean mass, recovery, sleep, and energy, based on its growth hormone axis Immune Related Adverse Events Linked to Immune Checkpoint Inhibitors: Retrospective Analysis of a Single Center Veteran Population What should we report? Lessons learnt from the development and implementation of serious adverse event reporting procedures in non pharmacological trials in palliative care BMC Palliative Care Springer Nature Link CJC 1295 and Ipamorelin: Maximizing Health Benefits The Fountain Understanding Growth Hormone Peptides: Weight Loss and Vitality: Medical Weight Loss PDF) Safety and metabolic effects of tesamorelin, a growth hormone releasing factor analogue, in patients with type 2 diabetes: A randomized, placebo controlled trial